Scott Michael Palmer, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Vice-Chair for Research in the Department of Medicine
Professor in Immunology
Professor in Population Health Sciences
Core Faculty in Innovation & Entrepreneurship
Campus mail 2085 Msrb2 2 Genome Ct, Durham, NC 27710
Phone (919) 684-0245
Email address scott.palmer@duke.edu

Dr. Palmer leads a successful program of clinical, basic and translational research in transplantation and advanced lung diseases. He currently directs the pulmonary research program at the Duke Clinical Research Institute (DCRI) and serves as Vice Chair for Research in the Department of Medicine.

Dr. Palmer has over 150 peer reviewed publications, received numerous awards, including election into the American Society for Clinical Investigation (ASCI) in 2012, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He is also Associate Director of the Clinical Research Training Program at Duke and has personally mentored over 40 pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

His scientific accomplishments include the first human studies to demonstrate the importance of innate immunity in transplant rejection and completion of a prospective multicenter study that improved CMV prevention after lung transplantation.

Current basic projects in the lab are studying the role of the matrix in the activation of innate immunity in pulmonary transplant rejection, and epithelial injury and repair in the development of toxin induced bronchiolitis obliterans. Translational and human projects are studying predictors of lung transplant survival in the UNOS database, immune monitoring to predict CMV infection and acute rejection after lung transplantation, and the use of novel inhaled antibiotics in lung transplantation. The lab is also using cutting edge whole exome genetic sequencing to identify genetic predictors of transplant rejection.

Dr. Palmer also leads trials coordinated through the DCRI that study the natural history and investigate new treatments for idiopathic pulmonary fibrosis (IPF), chronic lung transplant rejection, and posttransplant cytomegalovirus infection.

Education and Training

  • Fellow, Pulmonary Medicine, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2000
  • M.D., Duke University, 1993

Publications

Hadjiliadis, Denis, Robert D. Davis, and Scott M. Palmer. “Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?.” Chest 122, no. 4 (October 2002): 1168–75.

PMID
12377838
Scholars@Duke

Palmer, Scott M., R Duane Davis, Denis Hadjiliadis, Marshall I. Hertz, David N. Howell, Fran E. Ward, Kay Savik, and Nancy L. Reinsmoen. “Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome..” Transplantation 74, no. 6 (September 2002): 799–804. https://doi.org/10.1097/01.tp.0000028254.63164.53.

PMID
12364858
Full Text

Clary, Greg L., Scott M. Palmer, and P Murali Doraiswamy. “Mood disorders and chronic obstructive pulmonary disease: current research and future needs..” Current Psychiatry Reports 4, no. 3 (June 2002): 213–21. https://doi.org/10.1007/s11920-002-0032-7.

PMID
12003685
Full Text

Wahidi, Momen M., James Ravenel, Scott M. Palmer, and H Page McAdams. “Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation..” Chest 121, no. 6 (June 2002): 2072–76. https://doi.org/10.1378/chest.121.6.2072.

PMID
12065382
Full Text

Hadjiliadis, Denis, Thomas A. Sporn, John R. Perfect, Victor F. Tapson, R Duane Davis, and Scott M. Palmer. “Outcome of lung transplantation in patients with mycetomas..” Chest 121, no. 1 (January 2002): 128–34.

PMID
11796441
Scholars@Duke

Reams, B Diane, and Scott M. Palmer. “Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis..” American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions 1, no. 2 (January 2002): 91–98. https://doi.org/10.1007/bf03256598.

PMID
14720063
Full Text

Hadjiliadis, D., V. F. Tapson, R. D. Davis, and S. M. Palmer. “Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation..” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation 20, no. 12 (December 2001): 1305–9. https://doi.org/10.1016/s1053-2498(01)00373-4.

PMID
11744414
Full Text

Marom, E. M., Y. W. Choi, S. M. Palmer, D. M. DeLong, M. D. Stuart, and H. P. McAdams. “Reperfusion edema after lung transplantation: effect of daclizumab..” Radiology 221, no. 2 (November 2001): 508–14. https://doi.org/10.1148/radiol.2212010381.

PMID
11687697
Full Text

Palmer, S. M., R. H. Drew, J. D. Whitehouse, V. F. Tapson, R. D. Davis, R. R. McConnell, S. S. Kanj, and J. R. Perfect. “Safety of aerosolized amphotericin B lipid complex in lung transplant recipients..” Transplantation 72, no. 3 (August 2001): 545–48. https://doi.org/10.1097/00007890-200108150-00036.

PMID
11502995
Full Text

Pages